These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10556867)

  • 1. Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG. The Odense Study.
    Nielsen H; Lolk A; Andersen K; Andersen J; Kragh-Sørensen P
    Int J Geriatr Psychiatry; 1999 Nov; 14(11):957-63. PubMed ID: 10556867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of very mild to severe dementia and Alzheimer's disease in Denmark: the Odense Study.
    Andersen K; Nielsen H; Lolk A; Andersen J; Becker I; Kragh-Sørensen P
    Neurology; 1999 Jan; 52(1):85-90. PubMed ID: 9921853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and incidence of dementia in Denmark. The Odense study].
    Andersen K; Lolk A; Nielsen H; Kragh-Sørensen P
    Ugeskr Laeger; 2000 Aug; 162(33):4386-90. PubMed ID: 10962962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG).
    Hon J; Huppert FA; Holland AJ; Watson P
    Br J Clin Psychol; 1999 Jun; 38(2):155-65. PubMed ID: 10389597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG).
    Schmand B; Walstra G; Lindeboom J; Teunisse S; Jonker C
    Psychol Med; 2000 May; 30(3):619-27. PubMed ID: 10883717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?
    Aprahamian I; Martinelli JE; Cecato J; Izbicki R; Yassuda MS
    Int Psychogeriatr; 2011 Feb; 23(1):96-101. PubMed ID: 20678300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAMCOG as a screening instrument for dementia: the Odense study. Cambridge Cognitive Examination.
    Lolk A; Nielsen H; Andersen K; Andersen J; Kragh-Sørensen P
    Acta Psychiatr Scand; 2000 Nov; 102(5):331-5. PubMed ID: 11098803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.
    Ball SL; Holland AJ; Huppert FA; Treppner P; Watson P; Hon J
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):611-20. PubMed ID: 15312062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.
    Agüero-Torres H; Fratiglioni L; Guo Z; Viitanen M; Winblad B
    J Am Geriatr Soc; 1998 Apr; 46(4):444-52. PubMed ID: 9560066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological differentiation between Alzheimer's disease and dementia with Lewy bodies in a memory clinic.
    Kawai Y; Miura R; Tsujimoto M; Sakurai T; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Kachi T; Toba K
    Psychogeriatrics; 2013 Sep; 13(3):157-63. PubMed ID: 25913764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological subgroups of dementia of the Alzheimer's type.
    Williams RN; McIntosh DE; Eells GT; Dean RS; Hendrie H
    Int J Neurosci; 1996 Oct; 87(1-2):79-90. PubMed ID: 8913821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
    Ballard C; Patel A; Oyebode F; Wilcock G
    Age Ageing; 1996 May; 25(3):209-13. PubMed ID: 8670554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of quantitative and qualitative features of category verbal fluency in incident Alzheimer's disease subjects: results from the PAQUID study.
    Auriacombe S; Lechevallier N; Amieva H; Harston S; Raoux N; Dartigues JF
    Dement Geriatr Cogn Disord; 2006; 21(4):260-6. PubMed ID: 16465054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual association test to detect early dementia of the Alzheimer type.
    Lindeboom J; Schmand B; Tulner L; Walstra G; Jonker C
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):126-33. PubMed ID: 12122168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds.
    Aprahamian I; Martinelli JE; Neri AL; Yassuda MS
    Int Psychogeriatr; 2010 Feb; 22(1):64-71. PubMed ID: 19814841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in performance in CAMCOG-R domains between old and oldest old patients with Alzheimer's disease.
    Canneti B; Mosqueira AJ; Carreras T; Gago-Veiga AB; Onsurbe C; Ruiz M; Vivancos J
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2018 Jul; 25(4):588-597. PubMed ID: 28705033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.
    Visser PJ; Verhey FR; Scheltens P; Cruts M; Ponds RW; Van Broeckhoven CL; Jolles J
    J Neurol; 2002 Mar; 249(3):312-9. PubMed ID: 11993532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.